Patterns and Predictors of Colorectal Cancer Test Use in the Adult U.S. Population

Cancer

Volumn 100, Issue 10, 2004, Pages 2093-2103

  Seeff, Laura C ^a   Nadel, Marion R ^a   Klabunde, Carrie N ^b   Thompson, Trevor ^a   Shapiro, Jean A ^a   Vernon, Sally W ^c   Coates, Ralph J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Colonoscopy; Colorectal cancer (CRC); Fetal occult blood test (FOBT); Mass screening; Sigmoidoscopy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER TEST; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE ACCESS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICARE; OCCULT BLOOD TEST; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECTOSCOPY; SIGMOIDOSCOPY; UNITED STATES;

AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; SIGMOIDOSCOPY; UNITED STATES;

EID: 2342469942     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20276     Document Type: Article

References (35)

1. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
3. Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
4. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
5. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
6. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1461.
7. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-437.
8. rd edition: periodic updates. July 2002. Available from URL: http://www.ahrq.gov/clinic/uspstf/uspscolo.htm [accessed 9 April 2004].
9. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin. 2001;51:38-75.
10. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
11. National Health Interview Survey survey description. Washington, DC: National Center for Health Statistics, March 2002. Available from URL: ftp://ftp.cdc.gov/pub/HealthStatistics/NCHS/Dataset-Documentation/NHIS/2000/ srvydesc. pdf [accessed 1 Nov 2003].
12. rd edition: periodic updates. February 2002. Available from URL: http://www.ahrq.gov/clinic/uspstf/uspsbrca.htm [accessed 9 April 2004].
13. rd edition: periodic updates. January 2003. Available from URL: http://www.ahrq.gov/clinic/uspstf/uspscerv.htm [accessed 9 April 2004].
14. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S465-S470.
15. U.S. Department of Health and Human Services. Physical activity and health: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
16. Stables GJ, Subar AF, Patterson BH, et al. Changes in vegetable and fruit consumption and awareness among US adults: results of the 1991 and 1997 5-A-Day for Better Health Program surveys. J Am Diet Assoc.2002;102:809-817.
17. National Cancer Institute. Fruit and vegetable screeners. Available from URL: http://riskfactor.cancer.gov/diet/screeners/fruitveg/scoring/allday.html [accessed 9 April 20041.
18. SAS statistical analysis software. Cary, NC: SAS Institute Inc., 1996.
19. SUDAAN software for the statistical analysis of correlated data. Research Triangle Park, NC: Research Triangle Institute, 1997.
20. Breslow NE, Day NE. Statistical methods in cancer research. Volume 2: the design and analysis of cohort studies. IARC Scientific Pub. No. 82. Lyon, France: International Agency for Research on Cancer, 1987:58-61.
21. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer screening and associated health behaviors. Am J Prev Med. 2001;21: 132-137.
22. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93:1704-1713.
23. Seeff LC, Shapiro JA, Nadel MR. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavorial Risk Factor Surveillance System. J Fam Pract. 2002;51: 761-766.
24. Nadel MR, Blackman D, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med. 2002;35:199-206.
25. Peterson SK, Vernon SW. A review of patient and physician adherence to colorectal cancer screening guidelines. Semin Colon Rectal Surg. 2000;11:58-72.
26. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care. 1998;36:257-270.
27. Coates RJ, Uhler RJ, Brogan DJ, et al. Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States). Cancer Causes Control. 2001;12: 431-442.
28. Vernon SW, Laville EA, Jackson GL. Participation in breast screening programs: a review. Soc Sci Med. 1990;30:1107-1118.
29. Norman SA, Talbott EO, Kuller LH, et al. Demographic, psychosocial, and medical correlates of Pap testing: a literature review. Am J Prev Med. 1991;7:219-226.
30. Bernstein AB, Thompson GB, Harlan LC. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med Care. 1991;29:196-209.
31. Brown ML, Potosky AL, Thompson GB, Kessler LG. The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey. Prev Med. 1990;19:562-574.
32. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged ≥ 50 years-United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52:193-196.
33. Lied TR, Sheingold S. HEDIS performance trends in Medicare managed care. Health Care Financ Rev. 2001;23:149-160.
34. Kupets R, Covens A. Strategies for the implementation of cervical and breast cancer screening of women by primary care physicians. Gynecol Oncol. 2001;83:186-197.
35. Swan J, Breen N, Coates RJ, Ballard-Barbash R. Progress in cancer screening practices in the U.S.: results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528-1540.